Johnson & Johnson Statement on Texas Opioid Settlement Agreement
NEW BRUNSWICK, N.J., October 26, 2021 – Johnson & Johnson and its U.S.-based Janssen Pharmaceutical Companies today announced a settlement agreement with the State of Texas and its participating subdivisions resolving their opioid-related claims against the Company. With this agreement, the Company is removed from the pending Texas state and subdivision litigation, including two bellwether trials scheduled for early 2022. The $297 million settlement with Texas is consistent with the terms of the previously announced nationwide opioid settlement agreement. The dollar amount to be received by the State is the pro-rated...
Source: Johnson and Johnson - October 26, 2021 Category: Pharmaceuticals Source Type: news
Eritrea: Who Supports the Development of the Reproductive, Maternal, Newborn, Child Health, Adolescent and Ageing 2022-2026 Strategic Plan in the State of Eritrea, 14th October 2021
[WHO-AFRO] With strong political commitment, the State of Eritrea has made enormous strides to improve the health and wellbeing of women and children since independence. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 26, 2021 Category: African Health Source Type: news
Cochrane India Network launches in online event
Cochrane is pleased to announce the launch of a new network of institutions from across India that will promote evidence-informed health care and policy in the country.TheCochrane India Network launched in an online event today featuring keynotes from prominent national and international presenters, including the Director General of the Indian Council of Medical Research Dr Balram Bhargav; Dr Vinod Paul who is a member of NITI Aayog; WHO Chief Scientist Dr Soumya Swaminathan and Cochrane ’s Editor in Chief Karla Soares-Weiser. Presentations from each of the affiliate institutions followed, and the event concluded with pl...
Source: Cochrane News and Events - October 25, 2021 Category: Information Technology Authors: Rachel Klabunde Source Type: news
Geisel Kicks Off Strategic Planning Process
On October 12, faculty, staff, students, and alumni from across the Geisel School of Medicine as well as other key stakeholders gathered for a half-day retreat to kick off the school’s 2021 Strategic Planning Process, which is expected to run through February 2022. This comprehensive process, involving all missions of the school, will engage the Geisel community in developing a plan to guide our future investments for growth, determining the direction of the school for many years to come. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - October 20, 2021 Category: Hospital Management Authors: Derik Hertel Tags: News Source Type: news
Johnson & Johnson Reports Q3 2021 Results
New Brunswick, N.J. (October 19, 2021) – Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2021. “Our third-quarter results demonstrate solid performance across Johnson & Johnson, driven by robust above-market results in Pharmaceuticals, ongoing recovery in Medical Devices, and strong growth in Consumer Health,” said Alex Gorsky, Chairman and Chief Executive Officer. “In the face of evolving marketplace dynamics resulting from the effects of COVID-19 and other global trends, we have continued to demonstrate the responsiveness and agility required to meet the needs of our stakeholders, ...
Source: Johnson and Johnson - October 19, 2021 Category: Pharmaceuticals Tags: Financial Source Type: news
Johnson & Johnson Takes Steps to Equitably Resolve All Current and Future Talc Claims
NEW BRUNSWICK, N.J., October 14, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that LTL Management LLC (LTL), a newly created and separate subsidiary of Johnson & Johnson, that was established to hold and manage claims in the cosmetic talc litigation, has filed for voluntary Chapter 11 bankruptcy protection. This filing is intended to resolve all claims related to cosmetic talc in a manner that is equitable to all parties, including any current and future claimants. Johnson & Johnson and its other affiliates did not file for bankruptcy protection and will continue to operate their busines...
Source: Johnson and Johnson - October 14, 2021 Category: Pharmaceuticals Tags: Latest News Source Type: news
Johnson & Johnson to Host Business Review Highlighting Pharmaceuticals
NEW BRUNSWICK, N.J. October 13, 2021 - Johnson & Johnson will hold a Business Review for the investment community on Thursday, November 18, 2021, in which company leaders will share a detailed review of its Pharmaceuticals business, differentiated strategy and robust pipeline, and long-term growth outlook.The Business Review will include:- Comprehensive Pipeline Overviews for our Six Therapeutic Areas and Data Sciences available on a virtual platform beginning at 9:00 a.m. ET on November 17, 2021- Live General Session on November 18, 2021 beginning at 8:30 a.m. ET and ending at approximately 1:00 p.m. ET, featuring:Ent...
Source: Johnson and Johnson - October 13, 2021 Category: Pharmaceuticals Source Type: news
Johnson & Johnson Announces Jessica Moore as Vice President of Investor Relations
NEW BRUNSWICK, N.J. October 12, 2021 – Johnson & Johnson (NYSE: JNJ) today announced the appointment of Jessica Moore to Vice President of Investor Relations for Johnson & Johnson, effective November 1, 2021. Ms. Moore will report to Mr. Joseph Wolk, Executive Vice President and Chief Financial Officer of the Company.Ms. Moore brings 20 years of strong, diverse and international financial experience spanning across Sales Operations, Corporate and Regional positions. Most recently, Ms. Moore served as the Vice President and Chief Financial Officer for the Janssen Pharmaceutical business in the EMEA Region where sh...
Source: Johnson and Johnson - October 12, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news
Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire, Effective December 31, 2021
NEW BRUNSWICK, N.J. (October 12, 2021) – Johnson & Johnson (NYSE: JNJ) today announced that Paul Stoffels M.D., currently Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson, will retire from the Company effective December 31, 2021.As the Vice Chairman of the Executive Committee and Chief Scientific Officer, Dr. Stoffels spearheaded the company’s research and product pipeline leading teams across sectors to set the company-wide mandate to discover and develop transformational healthcare solutions. Under his leadership, Johnson & Johnson revitalized its innovation pipel...
Source: Johnson and Johnson - October 12, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news
HHS: Request for comments on the draft Department Strategic Plan for FY 2022-2026
Notice from the Department of Health and Human Services (HHS) seeking comment on its draft Strategic Plan for Fiscal Years 2022-2026. The draft strategic plan articulates how HHS will achieve its mission through five strategic goals: 1) Protect and Strengthen Equitable Access to High Quality and Affordable Health Care; 2) Safeguard and Improve National and Global Health Conditions and Outcomes; 3) Strengthen Social Well-being, Equity, and Economic Resilience; 4) Restore Trust and Accelerate Advancements in Science and Research for All; and 5) Advance Strategic Management to Build Trust, Transparency, and Accountability. Co...
Source: Federal Register updates via the Rural Assistance Center - October 7, 2021 Category: Rural Health Source Type: news
Public Inspection: HHS: Draft Department Strategic Plan for FY 2022 - 2026
Pre-publication notice from the Department of Health and Human Services (HHS) seeking comment on its draft Strategic Plan for Fiscal Years 2022-2026. The draft strategic plan articulates how HHS will achieve its mission through five strategic goals: 1) Protect and Strengthen Equitable Access to High Quality and Affordable Health Care; 2) Safeguard and Improve National and Global Health Conditions and Outcomes; 3) Strengthen Social Well-being, Equity, and Economic Resilience; 4) Restore Trust and Accelerate Advancements in Science and Research for All; and 5) Advance Strategic Management to Build Trust, Transparency, and Ac...
Source: Federal Register updates via the Rural Assistance Center - October 5, 2021 Category: Rural Health Source Type: news
AMDA Completes Ambitious Strategic Plan for the Future
There has never been a more important — or more challenging — time to plan for the future and become proactive and agile in an unpredictable world. AMDA – The Society for Post-Acute and Long-Term Care Medicine has done just that with its 2021–2023 Strategic Plan. (Source: Caring for the Ages)
Source: Caring for the Ages - October 1, 2021 Category: Health Management Tags: News From the Society Source Type: news
NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS)
This initiative aims to continue the successful NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) program. This initiative is intended to encourage potentially transformative research from exceptional early-stage scientists. The NIMH BRAINS program plans to focus on research priorities and gap areas identified in the NIMH Strategic Plan for Research. (Source: National Institute of Mental Health)
Source: National Institute of Mental Health - September 29, 2021 Category: Psychiatry Authors: National Institute of Mental Health Source Type: news
Board Meeting Minutes, September 28, 2021
Board Members Present: Danny Sands, Debra Cobb, Eric Bersh, Brian Mack, Joe Ternullo, Sarah Krug, Mary Hennings, Matthew Holt, Jay Spitulnik, Dennis Reilly, Tim Blevins, Vera Rulon, Jan Oldenburg, Judy Danielson, John Grohol, Amber Soucy, Burt Rosen
Others in Attendance: Randy Houk, Vaughn Keller
Full attendance record available here.
Welcome – Hennings
Minutes from last board meeting: Bersh
Approved.
Treasurer-Membership Report: Cobb
$173,000. Projection to end of 2021, $135,000 (no income included).
Recognition of departing Board members: Hennings
Mary reads Jan Oldenburg and Burt Rosen’s resolutions. Mary ...
Source: Society for Participatory Medicine - September 28, 2021 Category: General Medicine Authors: Eric Bersh Tags: Board Minutes Source Type: news
Canada was already desperately short of nurses before COVID-19. Now nurses say they're hanging on by a thread
The COVID-19 pandemic has worsened Canada’s already critical nursing shortage, and experts say it’s going to take strategic planning, incentives and a lot of effort to make work life more sustainable for nurses to build a bigger workforce. (Source: CBC | Health)
Source: CBC | Health - September 15, 2021 Category: Consumer Health News Tags: Radio/White Coat, Black Art Source Type: news
